Health Catalyst, Inc.
HCAT
$4.11
-$0.32-7.22%
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | 6.02% | 3.50% | 3.67% | 1.16% | 8.56% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 6.02% | 3.50% | 3.67% | 1.16% | 8.56% |
| Cost of Revenue | 5.18% | 1.18% | 1.46% | 1.10% | 15.73% |
| Gross Profit | 7.13% | 6.50% | 6.23% | 1.22% | 0.44% |
| SG&A Expenses | -9.83% | -16.62% | -13.80% | 1.90% | -27.41% |
| Depreciation & Amortization | -0.37% | -2.03% | -0.73% | -4.27% | -11.66% |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -2.71% | -7.95% | -7.43% | -1.98% | -6.34% |
| Operating Income | 32.57% | 45.61% | 44.62% | 13.17% | 36.26% |
| Income Before Tax | 33.55% | 30.82% | 58.66% | 38.18% | 15.55% |
| Income Tax Expenses | 337.06% | -905.08% | -17.65% | 63.77% | 142.37% |
| Earnings from Continuing Operations | 31.80% | 33.16% | 58.56% | 37.97% | 15.29% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 31.80% | 33.16% | 58.56% | 37.97% | 15.29% |
| EBIT | 32.57% | 45.61% | 44.62% | 13.17% | 36.26% |
| EBITDA | 48.81% | 67.11% | 71.67% | 17.27% | 44.73% |
| EPS Basic | 37.16% | 37.30% | 60.88% | 41.26% | 19.68% |
| Normalized Basic EPS | 17.35% | 35.10% | 53.49% | 21.68% | 45.14% |
| EPS Diluted | 37.16% | 37.30% | 60.88% | 41.26% | 19.68% |
| Normalized Diluted EPS | 17.35% | 35.10% | 53.49% | 21.68% | 45.14% |
| Average Basic Shares Outstanding | 8.53% | 6.58% | 5.94% | 5.60% | 5.47% |
| Average Diluted Shares Outstanding | 8.53% | 6.58% | 5.94% | 5.60% | 5.47% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |
